Our History
Timeline
Two decades of growth, from a one-person consultancy in Ottawa to a global supplier of nuclear medicine isotopes, equipment and quality control instrumentation.
-
Founded isoSolutions Inc. (consulting company).
-
Founded isoSolutions Marketing & Management Inc. (product distribution company).
-
isoSolutions was co-founder of Cyclomedical Applications Group, a company providing medical cyclotron facility services and contract management.
isoSolutions was co-founder of Alpha IICH Inc., a company developing a supply of alpha emitting radioisotopes for radiotherapy.
-
Established Area Sales Manager for Latin American market.
-
Formed partnership with Vira Pharma GmbH, a German company that managed the European market while isoSolutions managed the North and South American markets.
-
Headquarters of isoSolutions moved from Ottawa, Ontario to Vancouver, British Columbia.
-
Appointed Marketing & Sales Manager, Asia.
-
Initiated marketing activities in China.
-
First exhibit at Society of Nuclear Medicine and Molecular Imaging Annual Meeting (Miami Beach).
-
Hired Executive Assistant to Managing Director.
Established new office space in West End of Vancouver.
Hired Marketing & Sales Manager, Latin America.
isoSolutions sponsors an annual Armstrong-Lepeska Science Marketing Scholarship at Langara College.
-
Hired Marketing & Sales Manager, Canada/USA.
First exhibit at Canadian Association of Nuclear Medicine (Calgary).
First exhibit at international congress (World Federation of Nuclear Medicine & Biology, Cancun).
-
First ALASBIMN exhibit (Asociación Latinoamericana de Sociedades de Biología y Medicina Nuclear, Punta del Este).
Established Order Desk.
First exhibit at Brazilian Congress of Nuclear Medicine and Biology (Rio de Janeiro).
-
isoSolutions celebrates 15th Anniversary.
isoSolutions launches re-designed web site
-
isoSolutions adds Elysia-raytest to product line
isoSolutions establishes first sales and marketing manager located in United States
A Customer Service Manager is appointed with responsibility for supplier and customer relations, order management, and logistics.
-
isoSolutions appoints Directors of Marketing & Sales, Customer Service and Administration
GMP grade non-carrier added Lutetium-177 is added to the product portfolio.
-
A new strategic commercial alliance is established with Fenix Medica to strengthen our presence in Latin America.
A Sales & Marketing Manager for Asia is appointed, expanding the Asian team to three staff.
isoSolutions exhibits at the International Symposium on Targeted Alpha-Therapy.
isoSolutions attends the Chinese National Conference of Nuclear Medicine.
-
isoSolutions joins the Canadian Nuclear Isotope Council.
Founder started transition to retirement as Strategic Consultant, and new Managing Director was appointed.
-
A dedicated sales and service team was formed for QC instruments portfolio including Elysia-raytest products.
isoSolutions signs exclusive agreement with QBIOMED to distribute Strontium Sr-89 in Canada.
isoSolutions signs exclusive agreement with Isotopia to distribute Lutetium Lu-177 in Canada.
-
Acquired A.S.D. Inc.
-
Granted First U.S. Patent by the USPTO